Activation of NRF2 by celastrol increases antioxidant functions and prevents the progression of osteoarthritis in mice

Abstract

Excessive oxidative stress impairs cartilage matrix metabolism balance, significantly contributing to osteoarthritis (OA) development. Celastrol (CSL), a drug derived from Tripterygium wilfordii, has recognized applications in the treatment of cancer and immune system disorders, yet its antioxidative stress mechanisms in OA remain underexplored. This study aimed to substantiate CSL’s chondroprotective effects and unravel its underlying mechanisms. We investigated CSL’s impact on chondrocytes under both normal and inflammatory conditions. In vitro, CSL mitigated interleukin (IL)-1β-induced activation of proteinases and promoted cartilage extracellular matrix (ECM) synthesis. In vivo, intra-articular injection of CSL ameliorated cartilage degeneration and mitigated subchondral bone lesions in OA mice. Mechanistically, it was found that inhibiting nuclear factor erythroid 2-related factor 2 (NRF2) abrogated CSL-mediated antioxidative functions and exacerbated the progression of OA. This study is the first to elucidate the role of CSL in the treatment of OA through the activation of NRF2, offering a novel therapeutic avenue for arthritis therapy.

Keywords

Osteoarthritis / Celastrol / Articular cartilage / Extracellular matrix / NRF2

References

[1] Pigeolet M, Jayaram A, Park KB, et al. Osteoarthritis in 2020 and beyond[J]. Lancet, 2021, 397(10279): 1059-1060.

[2] Tang X, Wang S, Zhan S, et al. The prevalence of symptomatic knee osteoarthritis in China: results from the China health and retirement longitudinal study[J]. Arthritis Rheumatol, 2016, 68(3): 648-53.

[3] Phillips RE. Review of hip and knee osteoarthritis[J]. JAMA, 2021, 325(24): 2504-2505.

[4] Roos EM, Herzog W, Block JA, et al. Muscle weakness, afferent sensory dysfunction and exercise in knee osteoarthritis[J]. Nat Rev Rheumatol, 2011, 7(1): 57-63.

[5] Chen D, Shen J, Zhao W, et al. Osteoarthritis: toward a comprehensive understanding of pathological mechanism[J]. Bone Res, 2017, 5: 16044.

[6] Nelson KJ, Bolduc JA, Wu H, et al. H₍₂₎O₍₂₎ oxidation of cysteine residues in c-Jun N-terminal kinase 2 (JNK2) contributes to redox regulation in human articular chondrocytes[J]. J Biol Chem, 2018, 293(42): 16376-16389.

[7] Sun K, Jing X, Guo J, et al. Mitophagy in degenerative joint diseases[J]. Autophagy, 2021, 17(9): 2082-2092.

[8] LeBoeuf SE, Wu WL, Karakousi TR, et al. Activation of oxidative stress response in cancer generates a druggable dependency on exogenous non-essential amino acids[J]. Cell Metab, 2020, 31(2): 339-350.e4.

[9] Okazaki K, Anzawa H, Liu Z, et al. Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers[J]. Nat Commun, 2020, 11(1): 5911.

[10] Cuadrado A, Rojo AI, Wells G, et al. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases[J]. Nat Rev Drug Discov, 2019, 18(4): 295-317.

[11] Yang N, Li M, Wu L, et al. Peptide-anchored neutrophil membrane-coated biomimetic nanodrug for targeted treatment of rheumatoid arthritis[J]. J Nanobiotechnol, 2023, 21(1): 13.

[12] Liu Y, Li J. Self-assembling nanoarchitectonics of size-controllable celastrol nanoparticles for efficient cancer chemotherapy with reduced systemic toxicity[J]. J Colloid Interface Sci, 2023, 636: 216-222.

[13] Song XQ, Yu Z, Yang NN, et al. Molecular mechanism of celastrol in the treatment of systemic lupus erythematosus based on network pharmacology and molecular docking technology[J]. Life Sci, 2020, 240: 117063.

[14] Schroder A, Nazet U, Muschter D, et al. Impact of mechanical load on the expression profile of synovial fibroblasts from patients with and without osteoarthritis[J]. Int J Mol Sci, 2019, 20(3): 585.

[15] Zhou X, Zhang Y, Hou M, et al. Melatonin prevents cartilage degradation in early-stage osteoarthritis through activation of miR-146a/NRF2/HO-1 axis[J]. J Bone Miner Res, 2022, 37(5): 1056-1072.

[16] Bolduc JA, Collins JA, Loeser RF. Reactive oxygen species, aging and articular cartilage homeostasis[J]. Free Radic Biol Med, 2019, 132: 73-82.

[17] Shen C, Cai GQ, Peng JP, et al. Autophagy protects chondrocytes from glucocorticoids-induced apoptosis via ROS/Akt/FOXO3 signaling[J]. Osteoarthr Cartilage, 2015, 23(12): 2279-2287.

[18] Busa P, Lee SO, Huang N, et al. Carnosine alleviates knee osteoarthritis and promotes synoviocyte protection via activating the Nrf2/HO-1 signaling pathway: an in-vivo and in-vitro study[J]. Antioxidants (Basel), 2022, 11(6): 1209.

[19] Kannaiyan R, Shanmugam MK, Sethi G. Molecular targets of celastrol derived from thunder of god vine: potential role in the treatment of inflammatory disorders and cancer[J]. Cancer Lett, 2011, 303(1): 9-20.

[20] Chen XC, Lu Y, Liu Y, et al. Identification of a cytochrome P450 from Tripterygium hypoglaucum (Levl.) Hutch that catalyzes polpunonic acid formation in celastrol biosynthesis[J]. Chin J Nat Med, 2022, 20(9): 691-700.

[21] Corson TW, Crews CM. Molecular understanding and modern application of traditional medicines: triumphs and trials[J]. Cell, 2007, 130(5): 769-774.

[22] Venkatesha SH, Astry B, Nanjundaiah SM, et al. Suppression of autoimmune arthritis by celastrus-derived celastrol through modulation of pro-inflammatory chemokines[J]. Bioorg Med Chem, 2012, 20(17): 5229-5234.

[23] Deng YN, Shi J, Liu J, et al. Celastrol protects human neuroblastoma SH-SY5Y cells from rotenone-induced injury through induction of autophagy[J]. Neurochem Int, 2013, 63(1): 1-9.

[24] Wang W, Ha C, Lin T, et al. Celastrol attenuates pain and cartilage damage via SDF-1/CXCR4 signalling pathway in osteoarthritis rats[J]. J Pharm Pharmacol, 2018, 70(1): 81-88.

[25] Yang G, Wang K, Song H, et al. Celastrol ameliorates osteoarthritis via regulating TLR2/NF-kappaB signaling pathway[J]. Front Pharmacol, 2022, 13: 963506.

[26] Ding QH, Cheng Y, Chen WP, et al. Celastrol, an inhibitor of heat shock protein 90beta potently suppresses the expression of matrix metalloproteinases, inducible nitric oxide synthase and cyclooxygenase-2 in primary human osteoarthritic chondrocytes[J]. Eur J Pharmacol, 2013, 708(1-3): 1-7.

[27] Feng K, Chen H, Xu C. Chondro-protective effects of celastrol on osteoarthritis through autophagy activation and NF-kappaB signaling pathway inhibition[J]. Inflamm Res, 2020, 69(4): 385-400.

[28] Kim KH, Son JM, Benayoun BA, et al. The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress[J]. Cell Metab, 2018, 28(3): 516-524.e7.

[29] Khan NM, Ahmad I, Haqqi TM. Nrf2/ARE pathway attenuates oxidative and apoptotic response in human osteoarthritis chondrocytes by activating ERK1/2/ELK1-P70S6K-P90RSK signaling axis[J]. Free Radic Biol Med, 2018, 116: 159-171.

[30] Peng YJ, Lu JW, Lee CH, et al. Cardamonin attenuates inflammation and oxidative stress in interleukin-1beta-stimulated osteoarthritis chondrocyte through the Nrf2 pathway[J]. Antioxidants (Basel), 2021, 10(6): 862.

[31] Zhang Q, Bai X, Wang R, et al. 4-Octyl itaconate inhibits lipopolysaccharide (LPS)-induced osteoarthritis via activating Nrf2 signalling pathway [J]. J Cell Mol Med, 2022, 26(5): 1515-1529.

[32] Wang Y, Chen Y, Chen Y, et al. Eriodictyol inhibits IL-1beta-induced inflammatory response in human osteoarthritis chondrocytes[J]. Biomed Pharmacother, 2018, 107: 1128-1134.

[33] Wei Y, Jia J, Jin X, et al. Resveratrol ameliorates inflammatory damage and protects against osteoarthritis in a rat model of osteoarthritis[J]. Mol Med Rep, 2018, 17(1): 1493-1498.

[34] Li B, Jiang T, Liu H, et al. Andrographolide protects chondrocytes from oxidative stress injury by activation of the Keap1-Nrf2-Are signaling pathway[J]. J Cell Physiol, 2018, 234(1): 561-571.

[35] Xue EX, Lin JP, Zhang Y, et al. Pterostilbene inhibits inflammation and ROS production in chondrocytes by activating Nrf2 pathway[J]. Oncotarget, 2017, 8(26): 41988-42000.

Funding

Key Research and Development Plan of Jiangsu Province (Social Development Project(BE2021679)

National Natural Science Foundation Project(82171762)